Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8210603 | International Journal of Radiation Oncology*Biology*Physics | 2018 | 10 Pages |
Abstract
High single doses of radiation delivered as part of SBRT may induce an elevated and in some cases persistent state of tumor hypoxia in NSCLC tumors. Hypoxia imaging with 18F-fluoromisonidazole positron emission tomography should be used in a larger cohort of NSCLC patients to determine whether elevated tumor hypoxia is predictive of treatment failure in SBRT.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Olivia J. PhD, Roy H. MD, PhD, Sameer K. MD, Kimberly L. MD, PhD, Ming-Qiang PhD, Yiyun PhD, Jean-Dominique PhD, Chi PhD, Richard E. PhD, Uwe PhD, David J. PhD,